In vitro-selected linezolid-resistant Mycobacterium tuberculosis mutants

被引：77

作者：

Hillemann, Doris ^{[1
]}

Ruesch-Gerdes, Sabine ^{[1
]}

Richter, Elvira ^{[1
]}

机构：

[1] Natl Reference Ctr Mycbacteria, Forschungzentrum Borstel, D-23845 Borstel, Germany

来源：

ANTIMICROBIAL AGENTS AND CHEMOTHERAPY | 2008年 / 52卷 / 02期

关键词：

D O I：

10.1128/AAC.01189-07

中图分类号：

Q93 [微生物学];

学科分类号：

071005 ; 100705 ;

摘要：

引用

页码：800 / 801

页数：2

共 7 条

[1] In vitro selection of mutants of Streptococcus pneumoniae resistant to macrolides and linezolid:: relationship with susceptibility to penicillin G or macrolides [J].

Carsenti-Dellamonica, H ;

Galimand, M ;

Vandenbos, F ;

Pradier, C ;

Roger, PM ;

Dunais, B ;

Sabah, M ;

Mancini, G ;

Dellamonica, P .

JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2005, 56 (04) :633-642

[2] Linezolid for the treatment of multidrug-resistant tuberculosis [J].

Fortún, J ;

Martín-Dávila, P ;

Navas, E ;

Pérez-Elías, MJ ;

Cobo, J ;

Tato, M ;

De la Pedrosa, EGG ;

Gómez-Mampaso, E ;

Moreno, S .

JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2005, 56 (01) :180-185

[3] Antimicrobial resistance to linezolid [J].

Meka, VG ;

Gold, HS .

CLINICAL INFECTIOUS DISEASES, 2004, 39 (07) :1010-1015

[4] Resistance to linezolid: Characterization of mutations in rRNA and comparison of their occurrences in vancomycin-resistant enterococci [J].

Prystowsky, J ;

Siddiqui, F ;

Chosay, J ;

Shinabarger, DL ;

Millichap, J ;

Peterson, LR ;

Noskin, GA .

ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2001, 45 (07) :2154-2156

[5] First linezolid-resistant clinical isolates of Mycobacterium tuberculosis [J].

Richter, Elvira ;

Ruesch-Gerdes, Sabine ;

Hillemann, Doris .

ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2007, 51 (04) :1534-1536

[6] Ribosomal and non-ribosomal resistance to oxazolidinones: species-specific idiosyncrasy of ribosomal alterations [J].

Sander, P ;

Belova, L ;

Kidan, YG ;

Pfister, P ;

Mankin, AS ;

Bottger, EC .

MOLECULAR MICROBIOLOGY, 2002, 46 (05) :1295-1304

[7] Oxazolidinone resistance mutations in 23S rRNA of Escherichia coli reveal the central region of domain V as the primary site of drug action [J].

Xiong, LQ ;

Kloss, P ;

Douthwaite, S ;

Andersen, NM ;

Swaney, S ;

Shinabarger, DL ;

Mankin, AS .

JOURNAL OF BACTERIOLOGY, 2000, 182 (19) :5325-5331

← 1 →